Oracle Healthcare Data Repository 8.1.0 Nimbus JOSE+JWT exceptional condition
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 9.6 | $5k-$25k | 0.00 |
Summary
A vulnerability identified as very critical has been detected in Oracle Healthcare Data Repository 8.1.0. Affected is an unknown function of the component Nimbus JOSE+JWT. The manipulation leads to an unknown weakness. This vulnerability is referenced as CVE-2019-17195. Remote exploitation of the attack is possible. No exploit is available. You should upgrade the affected component.
Details
A vulnerability was found in Oracle Healthcare Data Repository 8.1.0 (Medical Device Software) and classified as very critical. This issue affects some unknown functionality of the component Nimbus JOSE+JWT. Using CWE to declare the problem leads to CWE-755. The product does not handle or incorrectly handles an exceptional condition. Impacted is confidentiality, integrity, and availability.
The weakness was published 10/19/2021 as Oracle Critical Patch Update Advisory - October 2021. The advisory is shared at oracle.com. The identification of this vulnerability is CVE-2019-17195. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 01/11/2026).
We expect the 0-day to have been worth approximately $25k-$100k. The vulnerability scanner Nessus provides a plugin with the ID 210560 (RHEL 8 : RHV Manager (ovirt-engine) 4.4 (RHSA-2020:3247)), which helps to determine the existence of the flaw in a target environment.
Upgrading eliminates this vulnerability. A possible mitigation has been published immediately after the disclosure of the vulnerability.
The vulnerability is also documented in the databases at Tenable (210560) and CERT Bund (WID-SEC-2022-0770). Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Affected
- IBM DB2
- Red Hat Enterprise Linux
- IBM SPSS
- EMC Avamar
- Hitachi Ops Center
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 9.8VulDB Meta Temp Score: 9.6
VulDB Base Score: 9.8
VulDB Temp Score: 9.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 9.8
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Exceptional conditionCWE: CWE-755
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Nessus ID: 210560
Nessus Name: RHEL 8 : RHV Manager (ovirt-engine) 4.4 (RHSA-2020:3247)
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍
Timeline
10/05/2019 🔍10/19/2021 🔍
10/19/2021 🔍
10/20/2021 🔍
01/11/2026 🔍
Sources
Vendor: oracle.comAdvisory: Oracle Critical Patch Update Advisory - October 2021
Status: Confirmed
Confirmation: 🔍
CVE: CVE-2019-17195 (🔍)
GCVE (CVE): GCVE-0-2019-17195
GCVE (VulDB): GCVE-100-184865
CERT Bund: WID-SEC-2022-0770 - IBM DB2: Mehrere Schwachstellen
Entry
Created: 10/20/2021 08:10Updated: 01/11/2026 21:32
Changes: 10/20/2021 08:10 (39), 10/25/2021 14:32 (3), 10/25/2021 14:34 (19), 11/10/2024 05:51 (16), 01/11/2026 21:32 (7)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.